375 related articles for article (PubMed ID: 10180653)
21. An ethical framework for the responsibilities of pharmacists when selling complementary medicines.
Salman Popattia A; La Caze A
Res Social Adm Pharm; 2021 May; 17(5):850-857. PubMed ID: 32747136
[TBL] [Abstract][Full Text] [Related]
22. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland.
Weidmann AE; MacLure K; Marshall S; Gray G; Stewart D
Int J Clin Pharm; 2015 Aug; 37(4):599-606. PubMed ID: 25822039
[TBL] [Abstract][Full Text] [Related]
23. Improving pharmacy practice in relation to complementary medicines: a qualitative study evaluating the acceptability and feasibility of a new ethical framework in Australia.
Popattia AS; Hattingh L; La Caze A
BMC Med Ethics; 2021 Jan; 22(1):3. PubMed ID: 33407396
[TBL] [Abstract][Full Text] [Related]
24. Feedback from community pharmacy users on the contribution of community pharmacy to improving the public's health: a systematic review of the peer reviewed and non-peer reviewed literature 1990-2002.
Anderson C; Blenkinsopp A; Armstrong M
Health Expect; 2004 Sep; 7(3):191-202. PubMed ID: 15327458
[TBL] [Abstract][Full Text] [Related]
25. Exploring oral healthcare management across Australian community pharmacies using case vignettes.
Taing MW; Firth N; Ford PJ; Freeman CR
Community Dent Oral Epidemiol; 2019 Jun; 47(3):225-235. PubMed ID: 30734359
[TBL] [Abstract][Full Text] [Related]
26. Consumers' expectations and experiences with chain community pharmacies in Lahore, Pakistan: a qualitative exploratory study.
Asif U; Saleem A; Masood I; Nawaz M
Int J Clin Pharm; 2019 Jun; 41(3):813-819. PubMed ID: 31028597
[TBL] [Abstract][Full Text] [Related]
27. A national survey exploring oral healthcare service provision across Australian community pharmacies.
Freeman CR; Abdullah N; Ford PJ; Taing MW
BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
[TBL] [Abstract][Full Text] [Related]
28. A model for assessment and referral of clients with bowel symptoms in community pharmacies.
Sriram D; McManus A; Emmerton LM; Parsons RW; Jiwa M
Curr Med Res Opin; 2016; 32(4):661-7. PubMed ID: 26700973
[TBL] [Abstract][Full Text] [Related]
29. Frequency, nature and determinants of pharmacy compounded medicines in Dutch community pharmacies.
Buurma H; de Smet PA; van den Hoff OP; Sysling H; Storimans M; Egberts AC
Pharm World Sci; 2003 Dec; 25(6):280-7. PubMed ID: 14689817
[TBL] [Abstract][Full Text] [Related]
30. Expectations and responsibilities regarding the sale of complementary medicines in pharmacies: perspectives of consumers and pharmacy support staff.
Iyer P; McFarland R; La Caze A
Int J Pharm Pract; 2017 Aug; 25(4):292-300. PubMed ID: 27633447
[TBL] [Abstract][Full Text] [Related]
31. Increasing clients' knowledge of community pharmacists' roles.
Chewning B; Schommer JC
Pharm Res; 1996 Sep; 13(9):1299-304. PubMed ID: 8893265
[TBL] [Abstract][Full Text] [Related]
32. Medication counselling and dispensing practices at community pharmacies: a comparative cross sectional study from Pakistan.
Hussain A; Ibrahim MI
Int J Clin Pharm; 2011 Oct; 33(5):859-67. PubMed ID: 21853362
[TBL] [Abstract][Full Text] [Related]
33. The provision of advice by pharmacy staff in eastern Indonesian community pharmacies.
Brata C; Schneider CR; Marjadi B; Clifford RM
Pharm Pract (Granada); 2019; 17(2):1452. PubMed ID: 31275500
[TBL] [Abstract][Full Text] [Related]
34. Purchasing restricted medicines in New Zealand pharmacies: results from a "mystery shopper" study.
Norris PT
Pharm World Sci; 2002 Aug; 24(4):149-53. PubMed ID: 12227248
[TBL] [Abstract][Full Text] [Related]
35. Providing patient care through community pharmacies in the UK: policy, practice, and research.
Noyce PR
Ann Pharmacother; 2007 May; 41(5):861-8. PubMed ID: 17456540
[TBL] [Abstract][Full Text] [Related]
36. Organisational factors associated with safety climate, patient satisfaction and self-reported medicines adherence in community pharmacies.
Jacobs S; Hann M; Bradley F; Elvey R; Fegan T; Halsall D; Hassell K; Wagner A; Schafheutle EI
Res Social Adm Pharm; 2020 Jul; 16(7):895-903. PubMed ID: 31558413
[TBL] [Abstract][Full Text] [Related]
37. The quality of private pharmacy services in low and middle-income countries: a systematic review.
Smith F
Pharm World Sci; 2009 Jun; 31(3):351-61. PubMed ID: 19343530
[TBL] [Abstract][Full Text] [Related]
38. Over the counter drugs. The interface between the community pharmacist and patients.
Bond CM; Bradley C
BMJ; 1996 Mar; 312(7033):758-60. PubMed ID: 8605465
[TBL] [Abstract][Full Text] [Related]
39. Employing the nominal group technique to explore the views of pharmacists, pharmacy assistants and women on community pharmacy weight management services and educational resources.
Fakih S; Marriott JL; Hussainy SY
Int J Pharm Pract; 2016 Apr; 24(2):86-96. PubMed ID: 26383046
[TBL] [Abstract][Full Text] [Related]
40. Non-prescription medicines: current issues in Australian community pharmacy.
Tan AC; Emmerton L
Int J Pharm Pract; 2009 Aug; 17(4):207-13. PubMed ID: 20217945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
